Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Rapid Micro Biosystems (RPID) Revenue (2020 - 2025)

Historic Revenue for Rapid Micro Biosystems (RPID) over the last 6 years, with Q3 2025 value amounting to $7.8 million.

  • Rapid Micro Biosystems' Revenue rose 307.73% to $7.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $30.5 million, marking a year-over-year increase of 1663.35%. This contributed to the annual value of $28.1 million for FY2024, which is 2456.59% up from last year.
  • As of Q3 2025, Rapid Micro Biosystems' Revenue stood at $7.8 million, which was up 307.73% from $7.3 million recorded in Q2 2025.
  • Rapid Micro Biosystems' 5-year Revenue high stood at $8.2 million for Q4 2024, and its period low was $3.9 million during Q2 2022.
  • Its 5-year average for Revenue is $6.0 million, with a median of $6.1 million in 2021.
  • As far as peak fluctuations go, Rapid Micro Biosystems' Revenue skyrocketed by 13640.57% in 2021, and later plummeted by 3703.1% in 2022.
  • Rapid Micro Biosystems' Revenue (Quarter) stood at $5.2 million in 2021, then fell by 16.01% to $4.4 million in 2022, then skyrocketed by 44.88% to $6.3 million in 2023, then increased by 29.68% to $8.2 million in 2024, then dropped by 4.62% to $7.8 million in 2025.
  • Its Revenue was $7.8 million in Q3 2025, compared to $7.3 million in Q2 2025 and $7.2 million in Q1 2025.